Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/21297a09-aa9b-4ab4-b13f-c095f19876b9/

PBYI

Puma Biotechnology Inc
Chart
$7.03
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.97
OS Score
80.0%
Value
97.0%
Quality
92.0%
Momentum
6/9
F-Score
0.881
QV
Strategy Eligibility
6 of 23 passing
OS Composite
OS 0.970
Trending Value
Quality × Value
QV 0.881
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
P/E 14.7
VC2 Cheapest
📐
EBITDA/EV
13.2%
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
💰
High Yield
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
Val 80th
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
RAM 1.32
V
Value Analysis
Cheapness relative to fundamentals
80.0%ile
P/E
14.7×
P/S
1.6×
P/B
2.8×
E/P
0.0682
FCF Yield
0.161
EBITDA/EV
0.132
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
20.00000000
/100 — 1=cheapest
VC2 (Trending Value)
28.00000000
/100
VC3 (Buyback)
28.00000000
/100
FCF yield of 16.1% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
97.0%ile
ROE
0.190
ROA
0.127
Net Margin
0.107
Op Margin
0.146
GPA
0.878
D/E
0.50
Current
2.38
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
-0.024
Earn Growth
-0.359
Stability
1.220
lower=better
Accruals
-0.152
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
92.0%ile
6M Return
32.6%
12M Return
89.0%
12-1 Mom
101.3%
Risk-Adj
1.32
Vol 252d
76.7%
Vol 60d
114.4%
↑ Expanding
Max DD 12M
-22.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 101% is very strong — a clear uptrend. Near-term vol (114%) is expanding vs long-term (77%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.97
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 500 peers
Sector Value %ile
88.4%
Sector Quality %ile
98.6%
P/E z-score
-0.20
P/B z-score
-0.18
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
GMRS GMR Solutions Inc. 95.0% 93.0% 86.0% 65.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (80th) and quality (97th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Trending Value Signal
Cheap (80th value) with strong momentum (92th). The market is starting to recognise the value.
Hot but Volatile
Strong momentum (92th) but high volatility (77%). Momentum could reverse sharply.
Volatility Expanding
60-day vol (114%) significantly exceeds 252-day (77%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
B
66.0% avg (7 factors)
Quality
B
73.6% avg (8 factors)
Momentum
A
84.1% avg (4 factors)
Risk
F
0.0% avg (1 factors)
This stock sits in the O'Shaughnessy sweet spot — cheap AND high quality. Historically, this combination has generated the strongest long-term returns. Momentum is confirming the value — this is the Trending Value signal that O'Shaughnessy found to be among the most powerful. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.970—1
Value %ile0.800—1
Quality %ile0.970—1
Momentum %ile0.920—1
F-Score6.000—0
Confidence1.000—1
Volatility0.767—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
14.66
Earnings Yield (E/P)
0.0682
Price / Sales
1.57
Price / Book
2.78
Price / Cash Flow
6.67
FCF Yield
16.1%
EBITDA / EV
13.2%
Sales Yield (1/P·S)
0.6829
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
19.0%
Return on Assets
12.7%
Net Margin
10.7%
Operating Margin
14.6%
Gross Profit / Assets
Novy-Marx GPA
87.8%
Debt / Equity
0.50
Current Ratio
2.38
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.152
MomentumPrice trend strength over different horizons
6M Return
32.6%
12M Return
89.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
101.3%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
1.32
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
-2.4%
Earnings Growth (YoY)
-35.9%
Earnings Stability (CV)
Lower = more stable
1.220
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
20
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
28
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
28
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity